QUEST MANAGEMENT INC. (OTCMKTS:QSMG) Files An 8-K Other Events

ME Staff 8-k
-
0

QUEST MANAGEMENT INC. (OTCMKTS:QSMG) Files An 8-K Other Events

Item 8.01 Other Events.

On April 11, 2017, Quest Management Inc. (Quest), issued the
press release attached hereto as Exhibit 99.1

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit Number

Description

99.1

Press Release dated April 11, 2017 announcing the signing
of a Letter of Intent to acquire immunotherapy Biotech
company Stemvax, Inc., from Dr. Dwain
Morris-Irvin, PhD. Dr. Morris- Irvin will simultaneously
become CEO of the newly formed Biotech division of Quest.


About QUEST MANAGEMENT INC. (OTCMKTS:QSMG)

Quest Management Inc. is a development-stage company. The Company focuses on developing marketing channels to distribute third-party fitness equipment to wholesale markets in the United States. Its product line includes a series of fitness equipment products, including Fitness Equipment, Sports Equipment, Gym Equipment, Exercise Equipment and Bodybuilding Equipment. The Company’s initial focus is on the fitness equipment market for gyms.

QUEST MANAGEMENT INC. (OTCMKTS:QSMG) Recent Trading Information

QUEST MANAGEMENT INC. (OTCMKTS:QSMG) closed its last trading session up +0.140 at 0.940 with 0 shares trading hands.